Recent advances in liver-directed gene transfer vectors.

Area of Science:

• Molecular medicine
• Hepatocellular carcinoma (HCC) research
• Gene therapy applications

Background:

• Gene therapy is a promising approach in modern molecular medicine for treating hepatocellular carcinoma (HCC).
• Significant advancements in viral and non-viral vectors have been made over the past decade to improve liver gene therapy.
• The potential for gene therapy to revolutionize cancer treatment is substantial.

Purpose of the Study:

• To review liver-directed gene transfer vectors for hepatocellular carcinoma (HCC) treatment.
• To discuss the history and recent clinical applications of these vectors.
• To evaluate the challenges in achieving stable transgene expression in hepatocytes.

Main Methods:

• Comprehensive literature search of MEDLINE and Index Medicus (2004).
• Review of bibliographic sources, including books and review articles.
• Focus on liver-directed gene transfer vectors, their development, and clinical use.

Main Results:

• The primary objective of liver-directed gene therapy for HCC is achieving stable expression of therapeutic transgenes in hepatocytes.
• Efficient and stable gene engraftment and expression in human hepatocytes using vector systems remain a significant challenge.
• The study discusses the advantages and disadvantages of various engineered viral and non-viral vectors.

Conclusions:

• Liver gene therapy for HCC still requires considerable development.
• There is an urgent need for the creation of efficient and safe liver-directed gene transfer vectors.
• Further research is essential to overcome current limitations in vector design and delivery.